ALA 3.45% 14.0¢ arovella therapeutics limited

long termers, page-6

  1. 12,293 Posts.
    lightbulb Created with Sketch. 3762
    MMcar2,

    you are spot on. Everytime PH does a licencing deal he gets the big stake (skin in the game ) holders want. Look at IMU and CHM. Same will happen here if he lands the next one which is highly likely.

    The scenario is the following: The licence is paid by shares issued to the R&D team, let's assume City of Hope and PH & Co who organise the initial funds paid by Instos. That way the shell company ( SUD ) holders will actually pay hardly anything. But the number of shares will increase significantly. That way instos, CoH and management & Co will become major sh like in CHM and IMU. Of course we will end up with the minority and some dilution compared to todays SoI but the sp will be a lot higher than today.

    I expect any deal anns should drive sp to 10 -15c and then it will depend on the deal structure and shares / funds allocated how much SUD will be worth.

    It will rise awareness like it did for CHM and IMU.

    But again, all speculation at this stage but with a high chance to become a fact. Securing a holding now shouldn't be a too high risk imo at current sp level.

    Please DYOR and be patient.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
-0.005(3.45%)
Mkt cap ! $147.0M
Open High Low Value Volume
14.5¢ 15.0¢ 14.0¢ $95.42K 662.9K

Buyers (Bids)

No. Vol. Price($)
6 168013 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.0¢ 1440985 13
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.